CYP2C19 status and risk of major adverse cardiovascular events in peripheral artery disease: Insights from the EUCLID Trial.

Gutierrez, J Antonio; Heizer, Gretchen M; Jones, W Schuyler; Rockhold, Frank W; Mahaffey, Kenneth W; Fowkes, F Gerry R; Berger, Jeffrey S; Baumgartner, Iris; Held, Peter; Katona, Brian G; Norgren, Lars; Blomster, Juuso I; Hiatt, William R; Patel, Manesh R (2020). CYP2C19 status and risk of major adverse cardiovascular events in peripheral artery disease: Insights from the EUCLID Trial. American Heart Journal, 229, pp. 118-120. Elsevier 10.1016/j.ahj.2020.07.017

[img] Text
GutierrezJA_CYP2C19StatusAndRisk_ResearchLetter_AnHeartJ_2020.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (153kB)

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Angiology

UniBE Contributor:

Baumgartner, Iris

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0002-8703

Publisher:

Elsevier

Language:

English

Submitter:

Rebecca Scheidegger

Date Deposited:

08 Dec 2020 11:47

Last Modified:

05 Dec 2022 15:42

Publisher DOI:

10.1016/j.ahj.2020.07.017

PubMed ID:

32950849

BORIS DOI:

10.7892/boris.149233

URI:

https://boris.unibe.ch/id/eprint/149233

Actions (login required)

Edit item Edit item
Provide Feedback